Financial News · Live Terminal

Page 31 of 193

Truist Securities Adjusts Price Target on Edgewise Therapeutics to $52 From $46, Maintains Buy Rating

Edgewise Therapeutics (EWTX) has an average rating of buy and mean price target of $42.75, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $37.70, Change: $-0.31, Percent Change: -0.82%

$EWTX

Australia3d ago

Truist Securities Adjusts Price Target on Cummins to $815 From $730, Maintains Buy Rating

Cummins (CMI) has an average rating of overweight and mean price target of $711.65, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $698.18, Change: $+23.30, Percent Change: +3.45%

$CMI

Australia3d ago

EPAM Systems, Anthropic Partner on Enterprise AI Adoption

EPAM Systems (EPAM) said Wednesday it is collaborating with Amazon-backed (AMZN) Anthropic to help enterprises accelerate adoption of artificial intelligence technologies, including workflow automation, legacy system modernization and large-scale data analysis.Financial details weren't disclosed.The collaboration will combine EPAM's engineering capabilities with Anthropic's Claude models, Claude Code and Claude Agent SDK to deliver enterprise-grade AI solutions focused on operational efficiency and reliability, the company said.Price: $108.39, Change: $-1.26, Percent Change: -1.14%

$AMZN$EPAM

Australia3d ago

UBS Adjusts Goldman Sachs Price Target to $940 From $930

Goldman Sachs Group (GS) has an average rating of Hold and mean price target of $956, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $932.31, Change: $+13.42, Percent Change: +1.46%

$GS

Australia3d ago

UBS Adjusts Bank of America Price Target to $63 From $62

Bank of America Corp (BAC) has an average rating of Buy and mean price target of $62.20, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $53.70, Change: $+0.58, Percent Change: +1.08%

$BAC

Australia3d ago

UBS Adjusts Capital One Financial Price Target to $270 From $283

Capital One Financial Corp (COF) has an average rating of overweight and mean price target of $255.81, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $194.16, Change: $+4.48, Percent Change: +2.36%

$COF

Australia3d ago

UBS Adjusts JPMorgan Chase Price Target to $375 From $380

JPMorgan Chase & Co (JPM) has an average rating of overweight and mean price target of $345.57, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $313.85, Change: $+4.45, Percent Change: +1.44%

$JPM

Australia3d ago

UBS Adjusts Wells Fargo Price Target to $105 From $113

Wells Fargo & Company (WFC) has an average rating of overweight and mean price target of $96.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $80.78, Change: $+0.89, Percent Change: +1.11%

$WFC

Australia3d ago

UBS Adjusts Morgan Stanley Price Target to $214 From $196

Morgan Stanley (MS) has an average rating of overweight and mean price target of $205.41, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $192.80, Change: $+3.54, Percent Change: +1.87%

$MS

Australia3d ago

InMode Share Fall After Q1 Non-GAAP Earnings Miss Estimates

InMode's (INMD) shares were down more than 6% in Wednesday trading after the company reported Q1 results that missed analyst expectations on earnings and issued a weaker-than-expected 2026 earnings outlook.The company reported Q1 non-GAAP earnings of $0.25 per diluted share, down from $0.31 a year earlier.Analysts polled by FactSet expected $0.29.Revenue for the quarter ended March 31 was $82 million compared with $77.9 million a year earlier.Four analysts surveyed by FactSet expected $80.3 million.The company said it now expects 2026 adjusted EPS in a range of $1.33 to $1.38, down from its previous guidance of $1.43 to $1.48. Analysts surveyed by FactSet expect $1.45.The company maintained its annual revenue guidance of between $365 million and $375 million. Analysts polled by FactSet expect $370 million.Price: $13.38, Change: $-1.02, Percent Change: -7.08%

$INMD

Australia3d ago

Western Digital Enters Equity-for-Equity Exchange Agreements

Western Digital (WDC) said Wednesday it has signed exchange agreements with institutional investors under which it will receive nearly 1.9 million shares of its own stock in exchange for 653,203 shares of Sandisk (SNDK).The exchanges are expected to settle on Thursday, Western Digital said.Western Digital said that upon settlement, it will continue to own about 1.04 million shares of Sandisk, which it intends to dispose of in one or more exchanges for Western Digital debt held by creditors and/or in exchange for outstanding shares of Western Digital common stock and/or through distributions to shareholders as dividends.Western Digital shares were fractionally higher in early trading Wednesday, while Sandisk was down 0.5%.Price: $467.20, Change: $+1.94, Percent Change: +0.42%

$SNDK$WDC

Australia3d ago

Wedbush Adjusts Price Target on Avalo Therapeutics to $40 From $29, Maintains Outperform Rating

Avalo Therapeutics Inc (AVTX) has an average rating of buy and mean price target of $44.40, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $19.53, Change: $+3.27, Percent Change: +20.11%

$AVTX

Australia3d ago

XPEL Shares Fall After Q1 Earnings, Revenue Increase

XPEL (XPEL) shares were down 2.7% in early trading on Wednesday after the company posted higher Q1 earnings and revenue.The company reported Q1 earnings Wednesday of $0.37 per diluted share, up from $0.31 a year earlier.Three analysts polled by FactSet expected $0.36.Total revenue for the quarter ended March 31 was $117.4 million, up from $103.8 million a year earlier.Three analysts polled by FactSet expected $113.1 million.The company said it expects Q2 revenue of $135 million to $137 million. Three analysts polled by FactSet expect $135.6 million.Price: $48.05, Change: $-1.32, Percent Change: -2.67%

$XPEL

Australia3d ago

UBS Adjusts Price Target on Waters to $375 From $330, Maintains Neutral Rating

Waters (WAT) has an average rating of overweight and mean price target of $399.10, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $343.69, Change: $+1.16, Percent Change: +0.34%

$WAT

Australia3d ago

FuboTV Shares Fall After Fiscal Q2 Net Loss Report

FuboTV (FUBO) shares fell more than 8% in Wednesday trading after the company reported a fiscal Q2 net loss.The company reported a fiscal Q2 net loss of $0.07 per diluted share.The company did not provide prior-year figures for comparison.Four analysts polled by FactSet expected a loss of $0.35.Revenue for the quarter ended March 31 was $1.57 billion, compared with $1.56 billion a year earlier.Analysts surveyed by FactSet expected $1.58 billion.Price: $11.41, Change: $-1.00, Percent Change: -8.02%

$FUBO

Australia3d ago

Wedbush Adjusts Price Target on Protagonist Therapeutics to $118 From $112, Maintains Outperform Rating

Protagonist Therapeutics (PTGX) has an average rating of buy and mean price target of $116.31, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $104.30, Change: $+5.09, Percent Change: +5.13%

$PTGX

Australia3d ago

UBS Adjusts Price Target on Versigent to $49 From $43, Maintains Buy Rating

Versigent (VGNT) has an average rating of buy and mean price target of $43.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.12, Change: $+2.62, Percent Change: +6.99%

$VGNT

Australia3d ago

Eli Lilly to Invest Additional $4.5 Billion in Indiana Manufacturing Sites

Eli Lilly (LLY) said Wednesday it will invest an additional $4.5 billion in two of its facilities in Lebanon, Indiana, bringing its total capital expansion commitments in the state to more than $21 billion since 2020.The additional investment will fund new process designs and technologies at Lilly Lebanon Advanced Therapies, a dedicated genetic medicine plant opening Wednesday, and Lilly Lebanon API, an active pharmaceutical ingredient facility expected to open in 2027, the company said.The Lebanon Advanced Therapies site is designed to handle operations ranging from clinical research to commercial production of therapies targeting diseases at the genetic level, Lilly said.The Lebanon campus will also include the planned Lilly Medicine Foundry facility, the company said.Price: $987.86, Change: $-0.61, Percent Change: -0.06%

$LLY

Australia3d ago

Aurora Innovation to Power Driverless Hauls in Texas for McLane

Aurora Innovation (AUR) and Berkshire Hathaway's (BRK.A, BRK.B) McLane subsidiary agreed to start driverless hauls in Texas using the Aurora Driver self-driving system, the companies said Wednesday.The companies started a supervised autonomy pilot of Aurora Driver in 2023, and has since logged over 280,000 autonomous miles in Texas and completed 1,400 load deliveries for McLane, according to the statement.McLane has approved driverless operations between Dallas and Houston, and Aurora targets to expand to new routes in McLane's distribution network in the US Sun Belt region by year-end, the companies said. No financial terms were disclosed.Price: $6.68, Change: $+0.15, Percent Change: +2.22%

$AUR$BRK.A$BRK.B

Australia3d ago

Weis Markets Shares Rise After Q1 Earnings, Net Sales Increase

Weis Markets (WMK) shares rose by more than 5% in early Wednesday trading after the company reported higher Q1 earnings and net sales.Q1 earnings increased to $1.13 per diluted share from $0.73 a year earlier, the company said.Net sales for the quarter ended March 28 were $1.25 billion, up from $1.2 billion a year earlier.Analyst estimates were not available for comparison.Price: $72.85, Change: $+3.35, Percent Change: +4.82%

$WMK

Showing 601-620 of 3847